Results 121 to 130 of about 4,213,516 (338)
The Frontiers of Product Liability for Adverse Reactions to the Contrast Medium [PDF]
Chang-Seon Lim
openalex +1 more source
High-pitch CT pulmonary angiography (CTPA) with ultra-low contrast medium volume for the detection of pulmonary embolism: a comparison with standard CTPA [PDF]
Tobias Schönfeld +9 more
openalex +1 more source
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié +16 more
wiley +1 more source
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker +16 more
wiley +1 more source
VesselTransGAN to CT Imaging: A Contrast Medium Free CTA Solution
Computed Tomography Angiography (CTA) is vital for detecting and planning treatment for vascular disease, but its use of contrast medium limits viability for patients with renal insufficiency.
Yun Hua +10 more
doaj +1 more source
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad +17 more
wiley +1 more source
Contrast-associated acute kidney injury, new findings and old believes [PDF]
Mohamad Ali Dayani +2 more
doaj +1 more source
An Individually Optimized Protocol of Contrast Medium Injection in Enhanced CT Scan for Liver Imaging [PDF]
Shi‐Ting Feng +9 more
openalex +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source

